drugset / Trial / NCT03180437

Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer

NCT03180437

RandomizedParallel-groupOpen-labelTreatment

Summary

In this study, effects of γδT cells on human Pancreatic Cancer in combination with tumor reducing surgery, for example IRE going to be investigated.

Timeline

Start
2017-06-15
Primary completion
2018-06-15
Completion
2019-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject γδ T cells Cell therapy